266 related articles for article (PubMed ID: 26639422)
1. BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.
Hirsch HH; Yakhontova K; Lu M; Manzetti J
Am J Transplant; 2016 Mar; 16(3):821-32. PubMed ID: 26639422
[TBL] [Abstract][Full Text] [Related]
2. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Study Evaluating the Effect of Different Immunosuppressive Agents on Human Polyomavirus BK Replication.
Favi E; Signorini L; Villani S; Dolci M; Ticozzi R; Basile G; Ferrante P; Ferraresso M; Delbue S
Transplant Proc; 2022 Sep; 54(7):2035-2041. PubMed ID: 35659782
[TBL] [Abstract][Full Text] [Related]
4. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
[TBL] [Abstract][Full Text] [Related]
5. The human fetal glial cell line SVG p12 contains infectious BK polyomavirus.
Henriksen S; Tylden GD; Dumoulin A; Sharma BN; Hirsch HH; Rinaldo CH
J Virol; 2014 Jul; 88(13):7556-68. PubMed ID: 24760884
[TBL] [Abstract][Full Text] [Related]
6. The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen.
Suwelack B; Malyar V; Koch M; Sester M; Sommerer C
Transplant Rev (Orlando); 2012 Jul; 26(3):201-11. PubMed ID: 21940156
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus and Other Mechanistic Target of Rapamycin Inhibitors Directly Activate Latent Pathogenic Human Polyomavirus Replication.
Alvarez Orellana J; Kwun HJ; Artusi S; Chang Y; Moore PS
J Infect Dis; 2021 Oct; 224(7):1160-1169. PubMed ID: 32060513
[TBL] [Abstract][Full Text] [Related]
8. Acitretin and Retinoic Acid Derivatives Inhibit BK Polyomavirus Replication in Primary Human Proximal Renal Tubular Epithelial and Urothelial Cells.
Wu Z; Graf FE; Hirsch HH
J Virol; 2021 Jul; 95(15):e0012721. PubMed ID: 34011542
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of BK virus replication in human kidney cells by BK virus large tumor antigen-specific shRNA delivered by JC virus-like particles.
Lin MC; Wang M; Fang CY; Chen PL; Shen CH; Chang D
Antiviral Res; 2014 Mar; 103():25-31. PubMed ID: 24406668
[TBL] [Abstract][Full Text] [Related]
10. CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
Mallat SG; Tanios BY; Itani HS; Lotfi T; McMullan C; Gabardi S; Akl EA; Azzi JR
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1321-1336. PubMed ID: 28576905
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
[TBL] [Abstract][Full Text] [Related]
12. Chk1 and the Host Cell DNA Damage Response as a Potential Antiviral Target in BK Polyomavirus Infection.
Hainley LE; Hughson MS; Narendran A; Smith R; Arthur J; Hayner-Buchan A; Conti DJ; Lehman JM; Friedrich TD
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372559
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
[TBL] [Abstract][Full Text] [Related]
14. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
16. Non-permissive human conventional CD1c+ dendritic cells enable trans-infection of human primary renal tubular epithelial cells and protect BK polyomavirus from neutralization.
Sikorski M; Coulon F; Peltier C; Braudeau C; Garcia A; Giraud M; Renaudin K; Kandel-Aznar C; Nedellec S; Hulin P; Branchereau J; Véziers J; Gaboriaud P; Touzé A; Burlaud-Gaillard J; Josien R; McIlroy D; Bressollette-Bodin C; Halary F
PLoS Pathog; 2021 Feb; 17(2):e1009042. PubMed ID: 33592065
[TBL] [Abstract][Full Text] [Related]
17. Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection.
Jiang M; Zhao L; Gamez M; Imperiale MJ
PLoS Pathog; 2012; 8(8):e1002898. PubMed ID: 22952448
[TBL] [Abstract][Full Text] [Related]
18. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Hirsch HH; Randhawa PS;
Clin Transplant; 2019 Sep; 33(9):e13528. PubMed ID: 30859620
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors of BK Virus Development in Kidney Transplant Recipients and the Effect of Low-Dose Tacrolimus Plus Everolimus on Clinical Outcomes.
Yilmaz VT; Kisaoglu A; Avanaz A; Dandin O; Ozel D; Mutlu D; Akkaya B; Aydinli B; Kocak H
Exp Clin Transplant; 2023 Sep; 21(9):727-734. PubMed ID: 37885288
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of calcineurin inhibitors as a risk factor for BK polyomavirus replication after kidney transplantation.
Krejčí K; Tichý T; Bednaříková J; Bartková M; Žamboch K; Orság J; Zadražil J
J Med Virol; 2021 Jun; 93(6):3871-3879. PubMed ID: 32940913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
